|
Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ (2003). Intracellular bacterial biofilm-like Pods in Urinary tract infections. Science 301:105-107.
Crossref
|
|
|
|
Anderson P, Engberg I, Lidin-Janson G, Lincoln K, Hull R, Hull S, Svanborg C (1991). Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infec. Immun. 59:2915-2921.
|
|
|
|
|
Balaban N, Gov Y, Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, Orlando F, D'amato G, Saba V, Scalise G, Bernes S (2004). A chimeric pep-tide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. Antimicrob. Agents Chemother. 48:2544-2550.
Crossref
|
|
|
|
|
Beloin C, Roux A, Ghigo JM (2008). Escherichia coli biofilms. Curr. Top. Microbiol. Immunol. 322:249-289.
Crossref
|
|
|
|
|
Brisset L, Vernet-Garnier V, Carquin J, Burde A, Flament JB, Choisy C (1996). In vivo and in vitro analysis of the ability of urinary catheters to microbial colonization. Pathol. Biol. 44:397-404.
|
|
|
|
|
Caiazza NC, O' Toole GA (2012). Sad B is required for the transition from reversible to irreversible attachment during biofilm formation by Pseudomonas aeruginosa PA1. J. Bacteriol. 189:4476-4485.
|
|
|
|
|
Carson L, Gorman SP, Gilmore BF (2010). The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli. FEMS Immunol. Med. Microbiol. 59:447-455.
Crossref
|
|
|
|
|
Cegelski L, Pinkner JS, Hammer ND (2009). Small- molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat. chem. Biol. 51: 913-919.
Crossref
|
|
|
|
|
Choong S, Wood S, Fry C, Whitfield H (2001). Catheter associated urinary tract infection and encrustation. Int. J. Antimicrob. Agents. 17:305-310.
Crossref
|
|
|
|
|
Christensen GD, Simpson WA, Younger JA, Baddour LM, Barrett FF,Melton DM, Beachey EH. Adherence of coagulase negative Staphylococci to plastic tissue culture a quantitative model for the adherence of staphylococci to medical devices. J. Clin. Microbiol. 22:996-1006
|
|
|
|
|
Costerton JW, Cheng KJ, Gessey GG (1987). Bacterial biofilms in nature and disease. Annu. Rev. Microbiol. 41:435-464.
Crossref
|
|
|
|
|
Costerton JW, Ellis B, Lam K, Johnson F, Khoury AE (1994). Mechanism of electrical enhancement of efficacy of antibiotics in killing biofilm bacteria. Antimicrob. Agents Chemother. 38:2803-2809.
Crossref
|
|
|
|
|
Costerton JW, Montanaro L, Arciola CR (2007). Bacterial communications in implant infections: a target for an intelligence war. Int. J. Artif. Organs 30(9):757-763.
|
|
|
|
|
Curtin JJ, Donlan RM (2006). Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob. Agents Chemother. 50:1268-1275.
Crossref
|
|
|
|
|
Danese PN, Pratt LA, Kolter R (2000). Exopolysaccharide production is required for development of Escherichia coli. K-12 biofilm architecture. J. Bacteriol. 182:3593-3596.
Crossref
|
|
|
|
|
Davenport K, Keeley FX (2005). Evidence for the use of silver-alloy-coated urethral catheters. J. Hosp. Inf. 60:298-303.
Crossref
|
|
|
|
|
Donlan RM (2001). Biofilms and device-associated infections. Emerg Infect Dis. 7:277.
Crossref
|
|
|
|
|
Donlan RM (2002). Biofilms: microbial life on Surfaces. Emerg. Infect. Dis. 9:88-890.
Crossref
|
|
|
|
|
Elliott TS, Moss HA, Tebbs SE, Wilson IC, Bonser RS, Graham TR (1992). Novel approach to investigate a source of microbial contamination of central venous catheters. Eur. J. Clin. Microbiol. Infect. Dis. 15:13-20
|
|
|
|
|
Ethers LJ, Bouwer JE (1999). RP4 Plasmid transfer among species of Pseudomonas in a biofilm reacter. Water Sci. Technol. 7:163-171.
|
|
|
|
|
Fey PD (2010). Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections? Curr. Opin. Microbiol. 13:610-615.
Crossref
|
|
|
|
|
Fisher LE, Hook AL, Ashraf W, Yousef A, Barrett DA, Scurr DJ, Chen X, Smith EF, Fay M, Parmenter CDJ, et al (2015). Biomaterial modification of urinary catheters with antimicrobials to give long-term broadspectrum antibiofilm activity. J. Control Release 202:57-64.
Crossref
|
|
|
|
|
Foo LY, Lu Y, Howell AB, Vorsa N (2000). A-type proantho-cyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. J Natural Prod. 63:1225-1228.
Crossref
|
|
|
|
|
Foo LY, Lu Y, Howell AB, Vorsa N (2000). The structure of cranberry proanthocyanidins which inhibit adherence of uropathogenic P-fimbriated Escherichia coli in vitro. Phyto-chemistry 54:173-181.
Crossref
|
|
|
|
|
Foxman B (2002). Epidemiology of urinary tract infection: Incidence morbidity and economic costs. Am. J. Med. 113:5S-13S.
Crossref
|
|
|
|
|
Freeman DJ, Falkiner FR, Keane CT (1989). A new method for the detection of the slime production by the coagulase negative Staphylococci. J. Clin. Pathol. 42: 872-874.
Crossref
|
|
|
|
|
Forster T, Fu W, Mayer O, Curtin J, Lehman SM, Donlan RM (2010). Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob. Agents Chemother. 54:397-404.
Crossref
|
|
|
|
|
Lohr G, Beikler T, Podbielski A, Standar K, Redanz S, Hensel A (2011). Polyphenols from Myrothamnus flabellifolia Welw. Inhibit in vitro adhesion of Porphyromonas gingivalis and exert anti-inflammatory cytoprotective effects in KB cells. J. Clin. Periodontol. 38:457-469.
Crossref
|
|
|
|
|
Garibaldi RA, Miller WA, Hebertson RM, Burke JP (1977). Antmicrobial prophylaxis for catheter-associated bacteriuria. Antmicrob. Agents Chemother. 11:240-243.
Crossref
|
|
|
|
|
Ghanwate NA (2012). Biofilm eradication studies on Uropathogenic E.coli using Ciprofloxacin and Nitofurantion. Int. J. Pharm. Biomed. Res. pp. 127-131.
|
|
|
|
|
Ghanwate NA, Thakare PV, Bhise PR, Tayde S (2014). Prevention of Biofilm formation in Urinary catheters by treatment with Antibiofilm agent. Int. J. Sci. Res. 3:714-717.
|
|
|
|
|
Giwercman B, Jensen E T, Hoiby N, Kharazmi A, Costerton W (1991). Induction of beta-lactamase production in Pseudomonas aeruginosa biofilm. Antimicrob. Agents Chemother. 35:1008-1010.
Crossref
|
|
|
|
|
Gorman SP, Jones DS (2003). Complications of urinary devices, in: Wilson, M Ed. Medical Implications of Biofilms. Cambridge University Press, Cambridge. UK. pp. 136-170.
Crossref
|
|
|
|
|
Grinholc M, Richter M, Nakonieczna J, Fila G, Bielawski KP (2011). The connection between grand SCC mec elements of Staphylococcus aureus strains and their response to photodynamic inactivation. Photomed. Laser Surg. 29:413-419.
Crossref
|
|
|
|
|
Grinholc M, Szramka B, Kurlenda J, Graczyk A, Bielawski KP (2008). Bactericidal effect of photodynamic inactivation against methicillin-resistant and methicillin-susceptible Staphylococcus aureus is strain-dependent. J. Photochem. Photobiol. 90:57-63.
Crossref
|
|
|
|
|
Grinholc M, Zawacka-Pankau J, Gwizdek-Wiśniewska A, Bielawski KP (2010). Evaluation of the role of the pharmacological inhibition of Staphylococcus aureus multidrug resistant pumps and the variable levels of the uptake of the sensitizer in the strain-dependent response of Staphylococcus aureus to PPArg2-based photo dynamic inactivation. Photochem. Photobiol. 86:1118-1126.
Crossref
|
|
|
|
|
Guiton PS, Hung CS, Kline KA, Roth R, Kau AL, et al (2009). Contribution of autolysin and Sortase A during Enterococcus faecalis DNA-dependent biofilm development. Infect. Immun. 77:3626-38.
Crossref
|
|
|
|
|
Hamblin MR, Hasan T (2004). Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem. Photo boil. Sci. 3:436-450.
|
|
|
|
|
Hensel Z, Xiao J (2009). A mechanism for stochastic decision making by bacteria. Chem. BioChem. 10: 974-976.
Crossref
|
|
|
|
|
Hinsa SM, Espinosaurgel E, Ramos JL, O' Toole GA (2003). Transition from reversible to irreversible attachment during biofilm formation by Pseudomonas fluorescenes WCS365 requires an ABC transporter and a large secreted protein. Mol. Micobiol. 49:905-918.
Crossref
|
|
|
|
|
Holland SP, Mathias RG, Morck DW, Chiu J, Slade SG (2000). Diffuse lamellar keratitides related to endotoxins released from sterilize reservoir biofilm. Opthalmology 107:1227-1234.
Crossref
|
|
|
|
|
Hong SH, Wang X, Wood TK (2010). Controlling biofilm formation, prophage excision and cell death by rewiring global regulator H-NS of Escherichia coli. Microb. Biotechnol. 3:344-356.
Crossref
|
|
|
|
|
Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, Saint S, Schaeer AJ, Tambayh PA, Tenke P, Nicolle LE (2010). Diagnosis, Prevention, and Treatment of Catheter Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin. Infect. Dis. 50(5):625-63.
Crossref
|
|
|
|
|
Hull RA, Donovan WH, Del Terzo M, Stewart C, Rogers M, Darouiche RO (2002). Role of type 1 fimbria- and P fimbria-specific adherence in colonization of the neurogenic human bladder by Escherichia coli. Infect. Immun. 70:6481-6484.
Crossref
|
|
|
|
|
Imamura Y, Higashiyama Y, Tomono K, Izumikawa K, Yanagihara K, Ohno H, Miyazaki Y, Hirakata Y, Mizuta Y, J Kadota, et al (2005). Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane. Antimicrob. Agents Chemother. 49:1377-1380.
Crossref
|
|
|
|
|
Jacobsen SM, Stickler DJ, Mobley HL, Shirtli ME (2008). Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol. Rev. 21:26-59.
Crossref
|
Jepson RG, Mihaljevic L, Craig J (2001). Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews. 3:
Crossref
|
|
|
|
Kaplan JB (2010). Biofilm dispersal mechanisms, clinical implications, and potential therapeutic uses. J. Dental Res. 89:205-218.
Crossref
|
|
|
|
|
Karatan E, Watnik P (2009). Signals, regulatory networks and materials that build and break bacterial biofilm. Microbiol. Mol. Biol. Rev. 73:310-347.
Crossref
|
|
|
|
|
Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K (2004). Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230:13-18.
Crossref
|
|
|
|
|
Keren I, Shah D, Spoering A, Kaldalu N, Lewis K (2004). Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186:8172-8180.
Crossref
|
|
|
|
|
Kharidia R, Liang J (2011). The activity of a small lytic peptide PTP-7 on Staphylococcus aureus biofilms. J. Microbiol. 49:663-668.
Crossref
|
|
|
|
|
Lappinscott HM, Bass C (2001). Biofilm formation: attachment, growth, and detachment of microbes from surfaces. Am. J. Infect. Control 29:250-251.
Crossref
|
|
|
|
|
Laue H, Schenk A, Li H (2006). Contribution of alginate and levan production to biofilm formation by Pseudomonas syrinage. Microbiology 152(10):2909-2918.
Crossref
|
|
|
|
|
Lellouche J, Friedman A, Gedanken A, Banin E (2012). Antibacterial and Antibiofilm properties of yttrium fluoride nanoparticles. Int. J. Nanomed. 7:5611-5624.
|
|
|
|
|
Lellouche J, Kahana E, Elias S, Gedanken A, Banin E (2009). Antibiofilm activity of nanosized magnesium fluoride. Biomaterials 30:5969-5978.
Crossref
|
|
|
|
|
Lemon KP, Higgins DE, Kolter (2007). Flagellar motility is critical for Listeria monocytogens biofilm formation. J. Bacteriol. 12:4418-4424.
Crossref
|
|
|
|
|
Lewis K (2001). Riddle of biofilm resistance. Antimicrobial Agents and Chemother 2001. 45:999-1007.
Crossref
|
|
|
|
|
Lewis K (2005). Persister cells and the riddle of biofilm survival. Biochemistry 70:267-274.
Crossref
|
|
|
|
|
Lewis K (2008). Multidrug tolerance of biofilms and persister cells. Curr. Top. Microbiol. Immun. 322:107-131.
Crossref
|
|
|
|
|
Lu TK, Collins JJ (2007). Dispersing biofilms with engineered enzymatic bacteriophage. Proc. Natl Acad. Sci. United States Am. 104:11197-1202.
Crossref
|
|
|
|
|
Mack D, Becker P, Chatterjee I, Dobinsky S, Knobloch JK, Peters G, Rohde H, Herrmann M. (2004). Mechanisms of biofilm formation in Staphylococcus epidermidis and Staphylococcus aureus: functional molecules, regulatory circuits, and adaptive responses. Int. J. Med. Microbiol. 294:203-212.
Crossref
|
|
|
|
|
Maria K, Maria H, Scott J (2014). Bacterial Biofilms: Development, Dispersal, and Therapeutic Strategies in the Dawn of the Postantibiotic Era. Cold Spring Harbor Laboratory Press.
|
|
|
|
|
Mathur S, Suller MT, Stickler DJ, Feneley RC (2006). Prospective study of individuals with long-term urinary catheters colonized with Proteus species. BJU Int. 97:121-128.
Crossref
|
|
|
|
|
Meluleni GJ, Grout M, Evans DJ, Pier GB (1995). Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharides capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients. J. Immunol. 155:2029-2038.
|
|
|
|
|
Morgan SD, Rigby D, Stickler DJ (2009). A study of the structure of the crystalline bacterial biofilms that can encrust and block silver Foley catheters. Urological Research. 37:89-93.
Crossref
|
|
|
|
|
Nakonieczna J, Michta E, Rybicka M, Grinholc M, Gwizdek-Wisniewska A, Bielawski KP (2010). Superoxide dis-mutase is upregulated in Staphylococcus aureus following protoporphyrin mediated photodynamic inactivation and does not directly influence the response to photodynamic treatment. BMC Microbiol. 10(1):323.
Crossref
|
|
|
|
|
Nickel JC, Ruseska I, Wright JB, Costerton JW (1985). Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob. Agents Chemother. 27:619-624.
Crossref
|
|
|
|
|
Niveditha S, Pramodhini S, Umadevi S, Shailesh Kumar, Selvaraj Stephen (2012). The isolation and biofilm formation of Uropathogens in the patients with catheter Associated urinary tract infections (UTIs). J. Clin. Diagn. Res. 6:1478-1482.
Crossref
|
|
|
|
|
Ong CY, Ulett GC, Mabbett AN et al (2008). Identification of type 3 fimbriae in uropathogenic Escherichia coli reveals a role in biofilm formation. J. Bacteriol. 190: 1054-1063.
Crossref
|
|
|
|
|
Otto G, Magnusson M, Svensson M, Braconier J, Svan-borg C (2001). Pap genotype and P fimbrial expression in Escherichia coli causing bacteremic and nonbacteremic febrile urinary tract infection. Clin. Infect. Dis. 32:1523-1531.
Crossref
|
|
|
|
|
Petrova OE, Sauer K (2010). The novel two- component regulatory system BfiSR regulates biofilm development by controlling the small RNA rsm Z through CafA. J. Bacteriol. 192:5275-5288.
Crossref
|
|
|
|
|
Pramodini S (2012). Antibiotic resistance pattern of biofilm-forming uropathogenic isolated from catheterized patients in Pondicherry. India Australas. med.J. 5:344-348.
Crossref
|
|
|
|
|
Qin Z, Yang L, Qu D, Molin S, Tolker-Nielsen T (2009). Pseudomonas aeruginosa extracellular products inhibit staphylococcal growth, and disrupt established biofilms produced by Staphylococcus epidermidis. Microbiology. 155:2148-2156.
Crossref
|
|
|
|
|
Raad II, Sabbagh MF, Rand KH, Sherertz RJ (1992). Quantitative tip culture methods and the diagnosis of central venous catheters related infections. Diagn. Microbiol. Infect. Dis. 15:13-20.
Crossref
|
|
|
|
|
Ramzan M, Bakhsh S, Salam A, Khan GM, Mustafa G (2004). Risk factors in urinary tract infection. Gomal J. Med. Sci. 2:1-4.
|
|
|
|
|
Reid G, Penstedt JD, Kang YS, Lam D, Nause C (1992). Microbial adhesion and biofilm formation on ureteral stents in vitro and in vivo. J. Urol. 148:1592-1594.
|
|
|
|
|
Rendueles O, Kaplan J, Ghigo J (2013). Antibiofilm polysaccharides. Environ. Microbiol. 15:334-346.
Crossref
|
|
|
|
|
Rowe MC, Withers HL, Wift S (1998). Uropathogenic Escherichia coli forms biofilm aggregates under iron restriction that disperses upon the supply of iron. FEMS Microbiol. Lett. 307:102-109.
Crossref
|
|
|
|
|
Roy A, Gauri SS, Bhattacharya M, Bhattacharya J (2013). Antimicrobial activity of CaO nanoparticles. J. Biomed. Nanotechnol. 9:1570-1578.
Crossref
|
|
|
|
|
Rupp ME, Fitzgerald T, Marion N, Helget V, Puumala S, Anderson JR, Fey PD (2004). Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance. Am. J. Infect. Control. 32:445-450.
Crossref
|
|
|
|
|
Sanchez Jr CJ, Mende K, Beckius ML Akers KS, Romano DR, Wenke JC, Murray CK (2013). Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect. Dis. 13:47.
Crossref
|
|
|
|
|
Sano M, Hirose T, Nishimura M, Takahashi S, Mat-sukawa M, Tsukamoto T (1999). Inhibitory action of clarithromycin on glycocalyx produced by MRSA. J. Infect. Chemother. 5:10-15.
Crossref
|
|
|
|
|
Schmidt T, Kirsching A (2012). Total synthesis of carolacton, a highly potent biofilm inhibitor. Angew Chem. Int. Ed. 51:1063-1066.
Crossref
|
|
|
|
|
Sepandj F, Ceri H, Gibb Read, Olson M (2003). Minimum inhibitory concentration versus minimum biofilm eliminating concentration in evaluation of antibiotic sensitivity of Gram negative bacilli causing perit. Dialysis Int. 24:65-67.
|
|
|
|
|
Shanks R, Sargent J, Martinez R, Graber M, O'Toole G (2006). Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol. Dial. Transpl. 21:2247-2255.
Crossref
|
|
|
|
|
Siddiq DM, Darouiche RO (2012). New strategies to prevent catheter-associated urinary tract infections. Nat. Rev. Urol. 9:305-314.
Crossref
|
|
|
|
|
Stickler D, Morris N, Moreno M, Sabbuba N (1998). Studies on the formation of crystalline bacterial biofilms on urethral catheters. Euro. J. Clin. Microbiol. Infect. Dis. 17:649-652.
Crossref
|
|
|
|
|
Stickler DJ, Zimako J (1994). Complications of urinary tract infections associated with devices used for long-term bladder management. J. Hosp. Infect. 28:177-94.
Crossref
|
|
|
|
|
Stickler DJ, Morris NS, McLean RJ, Fuqua C (1998). Biofilms on indwelling urethral catheters produce quorum-sensing signal molecules in situ and in vitro. Appl. Environ. Microbiol. 64:3486-90.
|
|
|
|
|
Stickler DJ (2014). Clinical complications of urinary catheters caused by crystalline biofilms: something needs to be done. J Int. Med. 276:120-129.
Crossref
|
|
|
|
|
Stowe SD, Richards JJ, Tucker AT, Thompson R, Melander C, Cavanagh J (2011). Anti-biofilm compounds derived from marine sponges. Marine Drugs 9:2010-2035.
Crossref
|
|
|
|
|
Suman E, Jose J, Varghese S, Kotian MS (2005). Study of biofilm production in Escherichia coli causing urinary tract infection. Indian J. Med. Microbiol. 25:1-3.
|
|
|
|
|
Thomas D, Day F (2007). Biofilm formation by plant associated bacteria. Ann. Rev. Microbiol. 61:401-422.
Crossref
|
|
|
|
|
Tool AG Kolter R (1998). Initiation of biofilm formation in Pseudomonas fluorescence WC5365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 28:449.
Crossref
|
|
|
|
|
Toutain CM, Caizza NC, Zegans ME, Toole GA (2007). Roles for flagellar stators in biofilm formation by Pseudomonas aeruginosa. Res. Microb. 158:471-477.
Crossref
|
|
|
|
|
Trautner BW, Darouiche RO (2004). Role of biofilm in catheter-associated urinary tract infection. Am. J. Infect. Control. 32:177-183.
Crossref
|
|
|
|
|
Trautner BW, Hull RA, Darouiche RO (2003). Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of Uropathogens. Urology 6:1059-1062.
Crossref
|
|
|
|
|
Trautner RO, Darouiche RA, Hull S, Hull JI, Thornby (2002). Pre-inoculation of urinary catheters with Escherichia coli 83972 inhibits catheter colonization by Enterococcus fecalis. J. Urol. 167:375-379.
Crossref
|
|
|
|
|
Ulett GC, Mabbett AN, Fung KC, Webb RI Schembri MA (2007). The role of F9 fimbriae of Uropathogenic Escherichia coli in Biofilm formation. Microbiology 153: 2321-2331.
Crossref
|
|
|
|
|
Van Acker H, Van Dijck P, Coenye T (2014). Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms. Trends Microbiol. 22:326-333.
Crossref
|
|
|
|
|
Warren JW (2001). Catheter associated urinary tract infection. Int. J. Antimicrob. Agent. 17:299-303.
Crossref
|
|
|
|
